Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Turid Aas

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Molecular Oncology|May 26, 2015
Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivoStian Knappskog, Elisabet O Berge, Ranjan Chrisanthar, et al.
Breast Cancer Research and Treatment|May 31, 2019
Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription DatabaseThomas Helland, Kari Britt Hagen, Martha Eimstad Haugstøyl, et al.
JCO Precision Oncology|December 1, 2023
Homologous Recombination Deficiency Across Subtypes of Primary Breast CancerSynnøve Yndestad, Christina Engebrethsen, Andrea Herencia-Ropero, et al.
BMJ Open|April 29, 2022
Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) studyHåvard Søiland, Emiel A M Janssen, Thomas Helland, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Molecular Oncology|May 26, 2015
Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivoStian Knappskog, Elisabet O Berge, Ranjan Chrisanthar, et al.
Breast Cancer Research and Treatment|May 31, 2019
Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription DatabaseThomas Helland, Kari Britt Hagen, Martha Eimstad Haugstøyl, et al.
JCO Precision Oncology|December 1, 2023
Homologous Recombination Deficiency Across Subtypes of Primary Breast CancerSynnøve Yndestad, Christina Engebrethsen, Andrea Herencia-Ropero, et al.
BMJ Open|April 29, 2022
Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) studyHåvard Søiland, Emiel A M Janssen, Thomas Helland, et al.
Pageof 5